{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:59:56Z","timestamp":1774047596091,"version":"3.50.1"},"posted":{"date-parts":[[2024,1,9]]},"group-title":"In Review","reference-count":76,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,12,4]]},"abstract":"<title>Abstract<\/title>\n        <p>The current demand for early intervention, prevention, and treatment of late onset Alzheimer\u2019s disease (LOAD) warrants deeper understanding of the underlying molecular processes which could contribute to biomarker and drug target discovery. Utilizing high-throughput proteomic measurements in serum from a prospective population-based cohort of older adults (n\u2009=\u20095,294), we identified 303 unique proteins associated with incident LOAD (median follow-up 12.8 years). Over 40% of these proteins were associated with LOAD <italic>independently<\/italic> of <italic>APOE-<\/italic>\u03b5<italic>4<\/italic> carrier status. These proteins were implicated in neuronal processes and overlapped with protein signatures of LOAD in brain and cerebrospinal fluid. We found 17 proteins which LOAD-association was strongly <italic>dependent<\/italic> on <italic>APOE-<\/italic>\u03b5<italic>4<\/italic> carrier status. Most of them showed consistent associations with LOAD in cerebrospinal fluid and a third had brain-specific gene expression. Remarkably, four proteins in this group (TBCA, ARL2, S100A13 and IRF6) were downregulated by <italic>APOE-<\/italic>\u03b5<italic>4<\/italic> yet upregulated as a consequence of LOAD as determined in a bi-directional Mendelian randomization analysis, reflecting a potential response to the disease onset. Accordingly, the direct association of these proteins to LOAD was reversed upon <italic>APOE-<\/italic>\u03b5<italic>4<\/italic> genotype adjustment, a finding which we replicate in an external cohort (n\u2009=\u2009719). Our findings provide an insight into the dysregulated pathways that may lead to the development and early detection of LOAD, including those both independent and dependent on <italic>APOE-<\/italic>\u03b5<italic>4<\/italic>. Importantly, many of the LOAD-associated proteins we find in the circulation have been found to be expressed - and have a direct link with AD - in brain tissue. Thus, the proteins identified here, and their upstream modulating pathways, provide a new source of circulating biomarker and therapeutic target candidates for LOAD.<\/p>","DOI":"10.21203\/rs.3.rs-3706206\/v1","type":"posted-content","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T15:57:49Z","timestamp":1704815869000},"source":"Crossref","is-referenced-by-count":1,"title":["Serum proteomics reveals APOE dependent and independent protein signatures in Alzheimer\u2019s disease"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7459-1603","authenticated-orcid":false,"given":"Valborg","family":"Gudmundsdottir","sequence":"first","affiliation":[{"name":"University of Iceland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Frick","sequence":"additional","affiliation":[{"name":"Icelandic Heart Association"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-0524","authenticated-orcid":false,"given":"Valur","family":"Emilsson","sequence":"additional","affiliation":[{"name":"Icelandic Heart Association"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9158-0087","authenticated-orcid":false,"given":"Thorarinn","family":"Jonmundsson","sequence":"additional","affiliation":[{"name":"Icelandic Heart Association"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Steindorsdottir","sequence":"additional","affiliation":[{"name":"University of Iceland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-2944","authenticated-orcid":false,"given":"Erik C.B.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Puerta","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2947-7606","authenticated-orcid":false,"given":"Eric","family":"Dammer","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anantharaman","family":"Shantaraman","sequence":"additional","affiliation":[{"name":"Goizueta Alzheimer's Disease Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Cano","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-3009","authenticated-orcid":false,"given":"Merce","family":"Boada","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic of Fundaci\u00f3 ACE, Institut Catal\u00e0 de Neuroci\u00e8ncies Aplicades-UIC, Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Valero","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Garcia-Gonzalez","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7661-4872","authenticated-orcid":false,"given":"Elias","family":"Gudmundsson","sequence":"additional","affiliation":[{"name":"Icelandic Heart Association"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Gudjonsson","sequence":"additional","affiliation":[{"name":"Icelandic Heart Association"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-414X","authenticated-orcid":false,"given":"Rebecca","family":"Pitts","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8397-2168","authenticated-orcid":false,"given":"Xiazi","family":"Qiu","sequence":"additional","affiliation":[{"name":"Novartis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Finkel","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9865-0494","authenticated-orcid":false,"given":"Anthony","family":"Orth","sequence":"additional","affiliation":[{"name":"Novartis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-624X","authenticated-orcid":false,"given":"Nicholas","family":"Seyfried","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-502X","authenticated-orcid":false,"given":"Allan","family":"Levey","sequence":"additional","affiliation":[{"name":"Emory"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2633-2495","authenticated-orcid":false,"given":"Agust\u00edn","family":"Ruiz","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3 ACE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7998-5433","authenticated-orcid":false,"given":"Thor","family":"Aspelund","sequence":"additional","affiliation":[{"name":"University of Iceland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5130-8417","authenticated-orcid":false,"given":"Lori","family":"Jennings","sequence":"additional","affiliation":[{"name":"Novartis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-7612","authenticated-orcid":false,"given":"Lenore","family":"Launer","sequence":"additional","affiliation":[{"name":"National Institute on Aging, National Institutes of Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-0084","authenticated-orcid":false,"given":"Vilmundur","family":"Gudnason","sequence":"additional","affiliation":[{"name":"Icelandic Heart Association"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz M","year":"2006","unstructured":"Gatz M et al (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63:168\u2013174","journal-title":"Arch Gen Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000512","article-title":"Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference?","volume":"6","author":"Reitz C","year":"2020","unstructured":"Reitz C, Rogaeva E, Beecham GW (2020) Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference? Neurol Genet 6,","journal-title":"Neurol Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population Estimate of People with Clinical AD and Mild Cognitive Impairment in the United States (2020\u20132060)","volume":"17","author":"Rajan KB","year":"2021","unstructured":"Rajan KB et al (2021) Population Estimate of People with Clinical AD and Mild Cognitive Impairment in the United States (2020\u20132060). Alzheimers Dement 17:1966","journal-title":"Alzheimers Dement"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer\u2019s Disease","volume":"388","author":"Dyck CH","year":"2023","unstructured":"van Dyck CH et al (2023) Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med 388:9\u201321","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in Early Alzheimer\u2019s Disease","volume":"384","author":"Mintun MA","year":"2021","unstructured":"Mintun MA et al (2021) Donanemab in Early Alzheimer\u2019s Disease. N Engl J Med 384:1691\u20131704","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-140669","article-title":"Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer\u2019s Disease","volume":"49","author":"Sattlecker M","year":"2016","unstructured":"Sattlecker M et al (2016) Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer\u2019s Disease. J Alzheimer\u2019s Disease 49:1105\u20131114","journal-title":"J Alzheimer\u2019s Disease"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-130380","article-title":"Candidate Blood Proteome Markers of Alzheimer\u2019s Disease Onset and Progression: A Systematic Review and Replication Study","volume":"38","author":"Kiddle SJ","year":"2014","unstructured":"Kiddle SJ et al (2014) Candidate Blood Proteome Markers of Alzheimer\u2019s Disease Onset and Progression: A Systematic Review and Replication Study. J Alzheimer\u2019s Disease 38:515\u2013531","journal-title":"J Alzheimer\u2019s Disease"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jalz.2013.09.016","article-title":"Alzheimer\u2019s disease biomarker discovery using SOMAscan multiplexed protein technology","volume":"10","author":"Sattlecker M","year":"2014","unstructured":"Sattlecker M et al (2014) Alzheimer\u2019s disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimer\u2019s & Dementia 10:724\u2013734","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archneurol.2010.215","article-title":"A Serum Protein-Based Algorithm for the Detection of Alzheimer\u2019s Disease","volume":"67","author":"O\u2019Bryant SE","year":"2010","unstructured":"O\u2019Bryant SE et al (2010) A Serum Protein-Based Algorithm for the Detection of Alzheimer\u2019s Disease. Arch Neurol 67:1077","journal-title":"Arch Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1021\/pr200270z","article-title":"Serum levels of pregnancy zone protein are elevated in presymptomatic alzheimer\u2019s disease","volume":"10","author":"Ijsselstijn L","year":"2011","unstructured":"Ijsselstijn L et al (2011) Serum levels of pregnancy zone protein are elevated in presymptomatic alzheimer\u2019s disease. J Proteome Res 10:4902\u20134910","journal-title":"J Proteome Res"},{"key":"ref11","author":"Ray S","year":"2007","unstructured":"Ray S et al (2007) Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins. Nature Medicine 2007 13:11 13, 1359\u20131362"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00702-012-0781-3","article-title":"Multidimensional plasma protein separation technique for identification of potential Alzheimer\u2019s disease plasma biomarkers: A pilot study","volume":"119","author":"Henkel AW","year":"2012","unstructured":"Henkel AW et al (2012) Multidimensional plasma protein separation technique for identification of potential Alzheimer\u2019s disease plasma biomarkers: A pilot study. J Neural Transm 119:779\u2013788","journal-title":"J Neural Transm"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/S0006-291X(02)00420-5","article-title":"Identification of oxidized plasma proteins in Alzheimer\u2019s disease","volume":"293","author":"Choi J","year":"2002","unstructured":"Choi J, Malakowsky CA, Talent JM, Conrad CC, Gracy RW (2002) Identification of oxidized plasma proteins in Alzheimer\u2019s disease. Biochem Biophys Res Commun 293:1566\u20131570","journal-title":"Biochem Biophys Res Commun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/prca.200780101","article-title":"Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer\u2019s disease in human plasma","volume":"2","author":"Cutler P","year":"2008","unstructured":"Cutler P et al (2008) Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer\u2019s disease in human plasma. Proteom Clin Appl 2:467\u2013477","journal-title":"Proteom Clin Appl"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/brain\/awl279","article-title":"Proteome-based plasma biomarkers for Alzheimer\u2019s disease","volume":"129","author":"Hye A","year":"2006","unstructured":"Hye A et al (2006) Proteome-based plasma biomarkers for Alzheimer\u2019s disease. Brain 129:3042\u20133050","journal-title":"Brain"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","article-title":"Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease","volume":"69","author":"Doecke JD","year":"2012","unstructured":"Doecke JD et al (2012) Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease. Arch Neurol 69:1318","journal-title":"Arch Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-130380","article-title":"Candidate Blood Proteome Markers of Alzheimer\u2019s Disease Onset and Progression: A Systematic Review and Replication Study","volume":"38","author":"Kiddle SJ","year":"2014","unstructured":"Kiddle SJ et al (2014) Candidate Blood Proteome Markers of Alzheimer\u2019s Disease Onset and Progression: A Systematic Review and Replication Study. J Alzheimer\u2019s Disease 38:515\u2013531","journal-title":"J Alzheimer\u2019s Disease"},{"key":"ref18","author":"Walker KA","year":"2021","unstructured":"Walker KA et al (2021) Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nature Aging 2021 1:5 1, 473\u2013489"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","volume":"2022","author":"Bellenguez C","year":"2022","unstructured":"Bellenguez C et al (2022) New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet 2022:1\u201325. 10.1038\/s41588-022-01024-z","journal-title":"Nat Genet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-021-00505-9","article-title":"Challenge accepted: uncovering the role of rare genetic variants in Alzheimer\u2019s disease","volume":"17","author":"Khani M","year":"2022","unstructured":"Khani M, Gibbons E, Bras J, Guerreiro R (2022) Challenge accepted: uncovering the role of rare genetic variants in Alzheimer\u2019s disease. Mol Neurodegener 17:3","journal-title":"Mol Neurodegener"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jnnp.65.1.103","article-title":"The prevalence of apoE-\u03b54 in Alzheimer\u2019s disease is age dependent","volume":"65","author":"Frisoni GB","year":"1998","unstructured":"Frisoni GB et al (1998) The prevalence of apoE-\u03b54 in Alzheimer\u2019s disease is age dependent. J Neurol Neurosurg Psychiatry 65:103","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-020-00740-0","article-title":"The association of APOE \u03b54 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study","volume":"13","author":"Gharbi-Meliani A","year":"2021","unstructured":"Gharbi-Meliani A et al (2021) The association of APOE \u03b54 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study. Alzheimers Res Ther 13,","journal-title":"Alzheimers Res Ther"},{"key":"ref23","author":"Corder EH","year":"1979","unstructured":"Corder EH et al (1979) Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer\u2019s Disease in Late Onset Families. Science () 261, 921\u2013923 (1993)"},{"key":"ref24","author":"Gudjonsson A","year":"2022","unstructured":"Gudjonsson A et al (2022) A genome-wide association study of serum proteins reveals shared loci with common diseases. Nature Communications 2022 13:1 13, 1\u201313"},{"key":"ref25","author":"Sun BB","year":"2018","unstructured":"Sun BB et al (2018) Genomic atlas of the human plasma proteome. Nature 2018 558:7708 558, 73\u201379"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaq1327","article-title":"Co-regulatory networks of human serum proteins link genetics to disease","volume":"361","author":"Emilsson V","year":"2018","unstructured":"Emilsson V et al (2018) Co-regulatory networks of human serum proteins link genetics to disease. Science 361,","journal-title":"Science"},{"key":"ref27","author":"Emilsson V","year":"2022","unstructured":"Emilsson V et al (2022) Coding and regulatory variants are associated with serum protein levels and disease. Nature Communications 2022 13:1 13, 1\u201311"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2814616\/v1","article-title":"Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer\u2019s disease","author":"Cruchaga C","year":"2023","unstructured":"Cruchaga C et al (2023) Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer\u2019s disease. Res Sq. 10.21203\/rs.3.rs-2814616\/v1","journal-title":"Res Sq"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","article-title":"Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders","volume":"24","author":"Yang C","year":"2021","unstructured":"Yang C et al (2021) Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat Neurosci 24:1302\u20131312","journal-title":"Nat Neurosci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/aje\/kwk115","article-title":"Age, Gene\/Environment Susceptibility \u2013 Reykjavik Study: Multidisciplinary Applied Phenomics","volume":"165","author":"Harris TB","year":"2007","unstructured":"Harris TB et al (2007) Age, Gene\/Environment Susceptibility \u2013 Reykjavik Study: Multidisciplinary Applied Phenomics. Am J Epidemiol 165:1076","journal-title":"Am J Epidemiol"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n M","year":"2015","unstructured":"Uhl\u00e9n M et al (2015) Proteomics. Tissue-based map of the human proteome. Science 347,","journal-title":"Science"},{"key":"ref32","author":"Li T","year":"2016","unstructured":"Li T et al (2016) A scored human protein\u2013protein interaction network to catalyze genomic interpretation. Nature Methods 2016 14:1 14, 61\u201364"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6068","article-title":"Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins","volume":"5","author":"Postmus I","year":"2014","unstructured":"Postmus I et al (2014) Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. Nat Commun 5,","journal-title":"Nat Commun"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"190","author":"Marucci G","year":"2021","unstructured":"Marucci G et al (2021) Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease. Neuropharmacology 190,","journal-title":"Neuropharmacology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease","volume":"53","author":"Ferkingstad E","year":"2021","unstructured":"Ferkingstad E et al (2021) Large-scale integration of the plasma proteome with genetics and disease. Nat Genet 53:1712\u20131721","journal-title":"Nat Genet"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1101\/2023.10.29.23297651","author":"Dammer EB","year":"2023","unstructured":"Dammer EB et al (2023) Proteomic Network Analysis of Alzheimer\u2019s Disease Cerebrospinal Fluid Reveals Alterations Associated with APOE \u03f54 Genotype and Atomoxetine Treatment. medRxiv 2023.10.29.23297651 10.1101\/2023.10.29.23297651"},{"key":"ref37","author":"Johnson ECB","year":"2022","unstructured":"Johnson ECB et al (2022) Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nature Neuroscience 2022 25:2 25, 213\u2013225"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-022-01113-5","article-title":"Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome","volume":"14","author":"Dammer EB","year":"2022","unstructured":"Dammer EB et al (2022) Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res Ther 14,","journal-title":"Alzheimers Res Ther"},{"key":"ref39","first-page":"14","article-title":"Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer\u2019s disease","volume":"7\u20138","author":"Porter T","year":"2018","unstructured":"Porter T et al (2018) Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer\u2019s disease. Pers Med Psychiatry 7\u20138:14\u201320","journal-title":"Pers Med Psychiatry"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12014-020-09285-8","article-title":"Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer\u2019s disease","volume":"17","author":"Zhou M","year":"2020","unstructured":"Zhou M et al (2020) Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer\u2019s disease. Clin Proteom 17:1\u201314","journal-title":"Clin Proteom"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/cdd.2008.191","article-title":"Netrin-1 interacts with amyloid precursor protein and regulates amyloid-beta production","volume":"16","author":"Louren\u00e7o FC","year":"2009","unstructured":"Louren\u00e7o FC et al (2009) Netrin-1 interacts with amyloid precursor protein and regulates amyloid-beta production. Cell Death Differ 16:655\u2013663","journal-title":"Cell Death Differ"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2016.06.030","article-title":"Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration","volume":"91","author":"Zetterberg H","year":"2016","unstructured":"Zetterberg H (2016) Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration. Neuron 91:1\u20133","journal-title":"Neuron"},{"key":"ref43","article-title":"Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury","volume":"13","author":"Graham NSN","year":"2021","unstructured":"Graham NSN et al (2021) Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury. Sci Transl Med 13,","journal-title":"Sci Transl Med"},{"key":"ref44","author":"Wolters F","year":"2016","unstructured":"Wolters F et al (2016) Von Willebrand Factor and the Risk of Dementia: A Population-Based Study (P1.092). Neurology 86,"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02476-4","article-title":"Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease","author":"Johnson ECB","year":"2023","unstructured":"Johnson ECB et al (2023) Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease. Nat Med. 10.1038\/s41591-023-02476-4","journal-title":"Nat Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jalz.2013.09.016","article-title":"Alzheimer\u2019s disease biomarker discovery using SOMAscan multiplexed protein technology","volume":"10","author":"Sattlecker M","year":"2014","unstructured":"Sattlecker M et al (2014) Alzheimer\u2019s disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimer\u2019s & Dementia 10:724\u2013734","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/alz.12419","article-title":"Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies","volume":"18","author":"Lindbohm JV","year":"2022","unstructured":"Lindbohm JV et al (2022) Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies. Alzheimer\u2019s & Dementia 18:612","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","article-title":"Large-scale plasma proteomics comparisons through genetics and disease associations","volume":"622","author":"Eldjarn GH","year":"2023","unstructured":"Eldjarn GH et al (2023) Large-scale plasma proteomics comparisons through genetics and disease associations. Nature 622:348\u2013358","journal-title":"Nature"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e13023","DOI":"10.1111\/acel.13023","article-title":"A serum protein signature of APOE genotypes in centenarians","volume":"18","author":"Sebastiani P","year":"2019","unstructured":"Sebastiani P et al (2019) A serum protein signature of APOE genotypes in centenarians. Aging Cell 18:e13023","journal-title":"Aging Cell"},{"key":"ref50","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n M","year":"2015","unstructured":"Uhl\u00e9n M et al (2015) Proteomics. Tissue-based map of the human proteome. Science 347,","journal-title":"Science"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","article-title":"The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019","volume":"47","author":"Buniello A","year":"2019","unstructured":"Buniello A et al (2019) The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res 47:D1005\u2013D1012","journal-title":"Nucleic Acids Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/mp.2015.23","article-title":"A NOVEL ALZHEIMER DISEASE LOCUS LOCATED NEAR THE GENE ENCODING TAU PROTEIN","volume":"21","author":"Jun G","year":"2016","unstructured":"Jun G et al (2016) A NOVEL ALZHEIMER DISEASE LOCUS LOCATED NEAR THE GENE ENCODING TAU PROTEIN. Mol Psychiatry 21:108","journal-title":"Mol Psychiatry"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41588-022-01016-z","article-title":"Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals","volume":"54","author":"Okbay A","year":"2022","unstructured":"Okbay A et al (2022) Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals. Nat Genet 54:437\u2013449","journal-title":"Nat Genet"},{"key":"ref54","author":"Brouwer RM","year":"2022","unstructured":"Brouwer RM et al (2022) Genetic variants associated with longitudinal changes in brain structure across the lifespan. Nature Neuroscience 2022 25:4 25, 421\u2013432"},{"key":"ref55","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04362-x","article-title":"Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function","volume":"9","author":"Davies G","year":"2018","unstructured":"Davies G et al (2018) Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun 9,","journal-title":"Nat Commun"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2020.04.025","article-title":"Genome-wide interaction analysis of pathological hallmarks in Alzheimer\u2019s disease","volume":"93","author":"Wang H","year":"2020","unstructured":"Wang H et al (2020) Genome-wide interaction analysis of pathological hallmarks in Alzheimer\u2019s disease. Neurobiol Aging 93:61\u201368","journal-title":"Neurobiol Aging"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/J.BPSGOS.2022.04.005","article-title":"Proteomic Analysis Identifies Circulating Proteins Associated With Plasma Amyloid \u03b2 and Incident Dementia","author":"Tin A","year":"2022","unstructured":"Tin A et al (2022) Proteomic Analysis Identifies Circulating Proteins Associated With Plasma Amyloid \u03b2 and Incident Dementia. Biol Psychiatry Global Open Sci. 10.1016\/J.BPSGOS.2022.04.005","journal-title":"Biol Psychiatry Global Open Sci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.2949367","article-title":"Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus","volume":"235","author":"Tanzi RE","year":"1987","unstructured":"Tanzi RE et al (1987) Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235:880\u2013884","journal-title":"Science"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"101794","DOI":"10.1016\/j.jbc.2022.101794","article-title":"Degradation and inhibition of epigenetic regulatory protein BRD4 exacerbate Alzheimer\u2019s disease-related neuropathology in cell models","volume":"298","author":"Zhang S","year":"2022","unstructured":"Zhang S et al (2022) Degradation and inhibition of epigenetic regulatory protein BRD4 exacerbate Alzheimer\u2019s disease-related neuropathology in cell models. J Biol Chem 298:101794","journal-title":"J Biol Chem"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/nn.4095","article-title":"D. BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice","volume":"18","author":"Korb E","year":"2015","unstructured":"Korb E, Herre M, Zucker-Scharff I, Darnell RB, Allis C (2015) D. BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice. Nat Neurosci 18:1464\u20131473","journal-title":"Nat Neurosci"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1073\/pnas.0308655100","article-title":"Binding of F-spondin to amyloid-beta precursor protein: a candidate amyloid-beta precursor protein ligand that modulates amyloid-beta precursor protein cleavage","volume":"101","author":"Ho A","year":"2004","unstructured":"Ho A, S\u00fcdhof TC (2004) Binding of F-spondin to amyloid-beta precursor protein: a candidate amyloid-beta precursor protein ligand that modulates amyloid-beta precursor protein cleavage. Proc Natl Acad Sci U S A 101:2548\u20132553","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/cr00081a005","article-title":"Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states","volume":"87","author":"Quinn DM","year":"1987","unstructured":"Quinn DM (1987) Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states. Chem Rev 87:955\u2013979","journal-title":"Chem Rev"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/ijms23031731","article-title":"The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders","volume":"23","author":"Lu\u00eds JP","year":"2022","unstructured":"Lu\u00eds JP, Sim\u00f5es CJV, Brito RMM (2022) The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders. Int J Mol Sci 23:1731","journal-title":"Int J Mol Sci"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ebiom.2016.06.002","article-title":"ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer\u2019s Disease","volume":"9","author":"Letronne F","year":"2016","unstructured":"Letronne F et al (2016) ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer\u2019s Disease. EBioMedicine 9:278\u2013292","journal-title":"EBioMedicine"},{"key":"ref65","author":"Leshchyns\u2019ka I","year":"2016","unstructured":"Leshchyns\u2019ka I, Sytnyk V (2016) Synaptic Cell Adhesion Molecules in Alzheimer\u2019s Disease. Neural Plast 6427537 (2016)"},{"key":"ref66","first-page":"65","article-title":"Cell adhesion molecules in Alzheimer\u2019s disease","volume":"2","author":"Wennstr\u00f6m M","year":"2012","unstructured":"Wennstr\u00f6m M, Nielsen HM (2012) Cell adhesion molecules in Alzheimer\u2019s disease. Degener Neurol Neuromuscul Dis 2:65\u201377","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"100372","DOI":"10.1016\/j.jbc.2021.100372","article-title":"Spatiotemporal processing of neural cell adhesion molecules 1 and 2 by BACE1 in vivo","volume":"296","author":"Kim W","year":"2021","unstructured":"Kim W, Watanabe H, Lomoio S, Tesco G (2021) Spatiotemporal processing of neural cell adhesion molecules 1 and 2 by BACE1 in vivo. J Biol Chem 296:100372","journal-title":"J Biol Chem"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-022-01356-1","article-title":"The amyloid plaque proteome in early onset Alzheimer\u2019s disease and Down syndrome","volume":"10","author":"Drummond E","year":"2022","unstructured":"Drummond E et al (2022) The amyloid plaque proteome in early onset Alzheimer\u2019s disease and Down syndrome. Acta Neuropathol Commun 10:53","journal-title":"Acta Neuropathol Commun"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-021-01119-4","article-title":"Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers","volume":"9","author":"Camporesi E","year":"2021","unstructured":"Camporesi E et al (2021) Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers. Acta Neuropathol Commun 9:19","journal-title":"Acta Neuropathol Commun"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbrc.2015.08.107","article-title":"The soluble extracellular fragment of neuroligin-1 targets A\u03b2 oligomers to the postsynaptic region of excitatory synapses","volume":"466","author":"Dinamarca MC","year":"2015","unstructured":"Dinamarca MC, Di Luca M, Godoy JA, Inestrosa NC (2015) The soluble extracellular fragment of neuroligin-1 targets A\u03b2 oligomers to the postsynaptic region of excitatory synapses. Biochem Biophys Res Commun 466:66\u201371","journal-title":"Biochem Biophys Res Commun"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.15252\/emmm.201404228","article-title":"Insulin\u2010like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice","volume":"6","author":"Pascual-Lucas M","year":"2014","unstructured":"Pascual-Lucas M et al (2014) Insulin\u2010like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice. EMBO Mol Med 6:1246\u20131262","journal-title":"EMBO Mol Med"},{"key":"ref72","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13430","article-title":"BACE1: More than just a \u03b2-secretase","volume":"23","author":"Taylor HA","year":"2022","unstructured":"Taylor HA, Przemylska L, Clavane EM, Meakin PJ (2022) BACE1: More than just a \u03b2-secretase. Obes Rev 23,","journal-title":"Obes Rev"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pbb.2013.03.003","article-title":"Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer\u2019s disease","volume":"107","author":"Wang D","year":"2013","unstructured":"Wang D et al (2013) Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer\u2019s disease. Pharmacol Biochem Behav 107:48\u201357","journal-title":"Pharmacol Biochem Behav"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-020-00377-5","article-title":"Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer\u2019s disease","volume":"15","author":"Rayaprolu S","year":"2020","unstructured":"Rayaprolu S et al (2020) Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer\u2019s disease. Mol Neurodegener 15:28","journal-title":"Mol Neurodegener"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression","volume":"73","author":"Zetterberg H","year":"2016","unstructured":"Zetterberg H et al (2016) Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression. JAMA Neurol 73:60","journal-title":"JAMA Neurol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41398-021-01677-0","article-title":"Genetically regulated expression in late-onset Alzheimer\u2019s disease implicates risk genes within known and novel loci","volume":"11","author":"Chen H","year":"2021","unstructured":"Chen H et al (2021) Genetically regulated expression in late-onset Alzheimer\u2019s disease implicates risk genes within known and novel loci. Transl Psychiatry 11:618","journal-title":"Transl Psychiatry"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3706206\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3706206\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T18:05:38Z","timestamp":1725473138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3706206\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":76,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3706206\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s43587-024-00693-1","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,1,9]]},"subtype":"preprint"}}